(Q72650455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

4

Zinkernagel RM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

Battegay M

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Kyburz D

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Hengartner H

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

3236-3241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Complement receptor mediates enhanced flavivirus replication in macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Vaccination for Disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Requirement for Θ-Bearing Cells in Lymphocytic Choriomeningitis Virus-induced Central Nervous System Disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

The biology of lymphocytic choriomeningitis infection: virus-induced immune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

A New Method to Detect Lymphocytic Choriomeningitis Virus-Specific Antibody in Human Sera

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognatevs. noncognate interactions in cytolysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Virus-induced delayed-type hypersensitivity reaction is sequentially mediated by CD8+ and CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Treatment of junin virus-infected guinea pigs with immune serum: development of late neurological disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

T cell memory is short-lived in the absence of antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231229

7 January 2021

Identifiers

DOI

10.1002/EJI.1830231229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258339%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference